CH452513A - Verfahren zur Herstellung von 1,5-Bisdehydrosteroiden - Google Patents

Verfahren zur Herstellung von 1,5-Bisdehydrosteroiden

Info

Publication number
CH452513A
CH452513A CH5764A CH5764A CH452513A CH 452513 A CH452513 A CH 452513A CH 5764 A CH5764 A CH 5764A CH 5764 A CH5764 A CH 5764A CH 452513 A CH452513 A CH 452513A
Authority
CH
Switzerland
Prior art keywords
bisdehydrosteroids
preparation
Prior art date
Application number
CH5764A
Other languages
German (de)
English (en)
Inventor
Tanabe Masato
L Shapiro Elliot
P Oliveto Eugene
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US251747A external-priority patent/US3127430A/en
Priority claimed from US251744A external-priority patent/US3127428A/en
Priority claimed from US263441A external-priority patent/US3332967A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of CH452513A publication Critical patent/CH452513A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A63—SPORTS; GAMES; AMUSEMENTS
    • A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
    • A63F1/00—Card games
    • A63F1/06—Card games appurtenances
    • A63F1/18—Score computers; Miscellaneous indicators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Multimedia (AREA)
  • Steroid Compounds (AREA)
CH5764A 1963-01-16 1964-01-07 Verfahren zur Herstellung von 1,5-Bisdehydrosteroiden CH452513A (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US251747A US3127430A (en) 1963-01-16 1963-01-16 17alpha-methyl-1, 5-androstadienes-17beta-ol-3-one and derivatives thereof
US251744A US3127428A (en) 1963-01-16 1963-01-16 Process for converting a 3-keto-delta-steroid to the corresponding 3-keto delta-compound
US263441A US3332967A (en) 1963-01-16 1963-03-07 3-hydroxy-1, 5-bis-dehydro steroids and methods for their manufacture
US31227363A 1963-09-30 1963-09-30

Publications (1)

Publication Number Publication Date
CH452513A true CH452513A (de) 1968-03-15

Family

ID=27500405

Family Applications (1)

Application Number Title Priority Date Filing Date
CH5764A CH452513A (de) 1963-01-16 1964-01-07 Verfahren zur Herstellung von 1,5-Bisdehydrosteroiden

Country Status (4)

Country Link
CH (1) CH452513A (en:Method)
DE (1) DE1493146A1 (en:Method)
DK (1) DK114971B (en:Method)
SE (1) SE314366B (en:Method)

Also Published As

Publication number Publication date
DK114971B (da) 1969-08-25
SE314366B (en:Method) 1969-09-08
DE1493146A1 (de) 1969-08-07

Similar Documents

Publication Publication Date Title
CH468966A (de) Verfahren zur Herstellung von 3-Aminotricyclo-(4,3,1,1,3,8)-undecan
CH459196A (de) Verfahren zur Herstellung von 4,6-Pregnadienderivaten
CH437316A (de) Verfahren zur Herstellung von substituierten Phenyl-amino-1,3-diazacyclopenten-(2)-Verbindungen
CH458587A (de) Verfahren zur Herstellung von 8,9,10,11-Tetrahydro-12-phthaloperinon
CH479574A (de) Verfahren zur Herstellung von 13-Jod-14-oxo 13,14-seco-steroiden
CH460766A (de) Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden
CH436317A (de) Verfahren zur Herstellung von 5-Joduracil-2'-desoxyribosid-3',5'-di-Estern
CH449610A (de) Verfahren zur Herstellung von Oestra-4,9-dien-3-olen
AT247866B (de) Verfahren zur Herstellung von 2, 6-Dichlorbenzonitril
CH446312A (de) Verfahren zur Herstellung von cis,cis-Cyclodecadien-(1,6)
CH437320A (de) Verfahren zur Herstellung von 4-Amino-5-hydroxypyridazonen (6)
CH451163A (de) Verfahren zur Herstellung von 2,2-Bipyridylium-dihalogeniden
CH445477A (de) Verfahren zur Herstellung von 1-Hydroxy-2,2,6,6-tetrachlorcyclohexankarbonamid-1
CH441352A (de) Verfahren zur Herstellung von 1-Phenyl-3-butyl-4-methyl-triazolon-(5)
CH459242A (de) Verfahren zur Herstellung von 1,2-Dihydro-1-hydroxy-1,3,5-triazinen
AT247848B (de) Verfahren zur Herstellung von 1, 3-Dioxo-2-alkylcyclopentanen
CH439328A (de) Verfahren zur Herstellung von 3,5-Dijodthyroninen
CH441583A (de) Verfahren zur Herstellung von 1,4-Diarylamino-5-nitro-8-hydroxy-anthrachinonen
CH435245A (de) Verfahren zur Herstellung von 1-Aryl-perchlor-2-aza-alkenen-(2)
CH427830A (de) Verfahren zur Herstellung von substituierten 1,4-Benzodiazepinen
CH444154A (de) Verfahren zur Herstellung von 1(10),2,4a(5)-A-Homoöstratrien-4-onderivaten
AT240356B (de) Verfahren zur Herstellung von neuen 1, 2-Diaryl-4-alkyl-3, 5-dioxo-pyrazolidinen
AT253703B (de) Verfahren zur Herstellung von 3, 6-Dioxo-A-nor-B-homo-steroiden
CH451151A (de) Verfahren zur Herstellung von 1,4-Benzoxazin-2-onen
CH471056A (de) Verfahren zur Herstellung von 2,5-Dialkoxybenzaldehyden